Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treatment of Patients With Acute Sinusitis in Daily Practice.

Next Previous
Search
Trial Profile

Treatment of Patients With Acute Sinusitis in Daily Practice.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Apr 2013

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Moxifloxacin (Primary)
  • Indications Acute sinusitis; Bacterial infections
  • Focus Therapeutic Use
  • Acronyms TOPAS
  • Sponsors Bayer

    • Most Recent Events

    • 21 Nov 2011 Actual end date changed from Mar 2008 to Dec 2008 as reported by ClinicalTrials.gov.
    • 02 Dec 2010 Actual initiation date changed from Mar 2006 to Mar 2007 as reported by ClinicalTrials.gov.
    • 02 Dec 2010 Actual end date changed from Dec 2008 to Mar 2008 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top